Related references
Note: Only part of the references are listed.Base and Covariate Population Pharmacokinetic Analyses of Dupilumab Using Phase 3 Data
Pavel Kovalenko et al.
CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT (2020)
Shadow cost of oral corticosteroids-related adverse events: A pharmacoeconomic evaluation applied to real-life data from the Severe Asthma Network in Italy (SANI) registry
Giorgio Walter Canonica et al.
WORLD ALLERGY ORGANIZATION JOURNAL (2019)
Oral corticosteroid exposure and adverse effects in asthmatic patients
Patrick W. Sullivan et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2018)
Postpartum Hemorrhage
Daneil L. Jackson et al.
OBSTETRICAL & GYNECOLOGICAL SURVEY (2018)
Targeting key proximal drivers of type 2 inflammation in disease
Namita A. Gandhi et al.
NATURE REVIEWS DRUG DISCOVERY (2016)
Exploratory Population PK Analysis of Dupilumab, a Fully Human Monoclonal Antibody Against IL-4R, in Atopic Dermatitis Patients and Normal Volunteers
P. Kovalenko et al.
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY (2016)
Type 2 inflammation in asthma - present in most, absent in many
John V. Fahy
NATURE REVIEWS IMMUNOLOGY (2015)
Risk factors for death in patients with severe asthma
Andreia Guedes Oliva Fernandes et al.
JORNAL BRASILEIRO DE PNEUMOLOGIA (2014)
Measures of gene expression in sputum cells can identify TH2-high and TH2-low subtypes of asthma
Michael C. Peters et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2014)
The relationship between asthma, asthma control and economic outcomes in the United States
Patrick W. Sullivan et al.
JOURNAL OF ASTHMA (2014)
Heterogeneity of phenotypes in severe asthmatics. The Belgian Severe Asthma Registry (BSAR)
F. Schleich et al.
RESPIRATORY MEDICINE (2014)
Asthma control and management in 8,000 European patients: the REcognise Asthma and LInk to Symptoms and Experience (REALISE) survey
David Price et al.
NPJ PRIMARY CARE RESPIRATORY MEDICINE (2014)
Establishing Best Practices and Guidance in Population Modeling: An Experience With an Internal Population Pharmacokinetic Analysis Guidance
W. Byon et al.
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY (2013)
Lebrikizumab Treatment in Adults with Asthma
Jonathan Corren et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Factors Associated With the Control of Severe Asthma
Juan Luis Rodriguez Hermosa et al.
JOURNAL OF ASTHMA (2010)
T-helper Type 2-driven Inflammation Defines Major Subphenotypes of Asthma
Prescott G. Woodruff et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2009)
Risk factors for death in adults with severe asthma
Theodore A. Omachi et al.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2008)
Real-world Evaluation of Asthma Control and Treatment (REACT): Findings from a national Web-based survey
Stephen P. Peters et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2007)
Can guideline-defined asthma control be achieved? The gaining optimal asthma control study
ED Bateman et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2004)
Share Paper
